RANI Therapeutics secures $1.085 billion Chugai deal and $60.3 million funding Nov 6, 2025 04:33PM
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update Nov 6, 2025 04:30PM
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: RA CAPITAL MANAGEMENT, L.P. Oct 30, 2025 04:36PM
Rani Therapeutics adds two directors, closes $60.3 million funding Oct 23, 2025 04:05PM
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors Oct 23, 2025 04:05PM


Oct 23, 2025 04:01PM Rani Therapeutics raises $60.3 million in oversubscribed private placement
Oct 23, 2025 04:01PM Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
Oct 17, 2025 07:31AM Rani Therapeutics raises $60.3 million in oversubscribed private placement
Oct 17, 2025 07:31AM Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
Oct 17, 2025 07:30AM Rani Therapeutics secures $1.085 billion collaboration deal with Chugai
Oct 17, 2025 07:30AM Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurre